Investment Rating - The industry investment rating is "Recommended" [3] Core Insights - L'Oréal's acquisition of approximately 10% of Galderma aims to enhance its skin science and medical aesthetics segments, indicating a trend towards the integration of medical aesthetics and beauty [8] - The performance of domestic brands is expected to continue strengthening, with potential to capture more market share from overseas competitors [6] - The overall retail environment is under pressure, prompting companies to reform their business models and improve efficiency [10] Summary by Sections Industry Overview - The total number of listed companies in the industry is 142, with a total share capital of 3,032.81 million shares [3] - The industry's sales revenue is approximately 758.46 billion RMB, and the total profit is around 120.41 billion RMB [3] - The average price-to-earnings (PE) ratio for the industry is 98.77, with an average stock price of 8.37 RMB [3] Key Company Developments - L'Oréal's acquisition of Galderma is expected to enhance its product offerings in the medical aesthetics sector, with Galderma's injection aesthetics revenue exceeding 50% in H1 2024, showing a year-on-year growth of 13.4% [8] - Shiseido reported a sales figure of approximately 24.91 billion RMB for H1 2024, reflecting a 2.9% increase, but core operating profit decreased by 31.3% [8] - Kao Corporation's H1 2024 net sales reached approximately 38.36 billion RMB, marking a 6.7% increase, with significant growth in its health and beauty care segment [8] - Amorepacific's Q2 2024 sales totaled approximately 4.69 billion RMB, down 4.3%, with a notable decline in the Greater China region [8] - e.l.f. Beauty's Q1 FY2025 net sales were approximately 2.33 billion RMB, a 50% increase, while net profit decreased by 10% due to increased marketing expenses [8] Market Trends - The medical aesthetics sector is expected to see continued growth, with new product launches and market expansion being key investment focal points for 2024 [7] - The retail sector is shifting focus from low-price strategies to GMV growth, benefiting beauty brands in the long term [10] - The import of cosmetics in July showed a decrease in quantity and value, indicating potential challenges in the market [8]